Washington, DC 20006-5349
HELPLINE
Earlier this week, we gathered with over 800 rare disease advocates at the 2018 Rare Diseases & Orphan Products Breakthrough Summit hosted in Washington, D.C.…
Last Friday, October 5, we made our second and final stop on the 2018 International Symposium on Malignant Mesothelioma tour in New York City! Executive…
We have exciting news! The next stop on the 2018 International Symposium on Malignant Mesothelioma tour is New York City on Friday, Oct. 5, 2018,…
Effective today, Aug. 1, the Meso Foundation’s new office location will be 1615 L Street NW, Suite 430, Washington, D.C. 20036. Our office numbers will…
This week, the Meso Foundation is happy to welcome two new members of our Washington, D.C. office staff: Michael Braeuninger and Jordan Fingerhut. Michael joins…
The Mesothelioma Applied Research Foundation (Meso Foundation) is excited to announce this week the addition of five new members to the Board of Directors: Richard…
A Russian asbestos company is now flippantly marketing its products with the face of President Donald Trump and his alleged approval. The Mesothelioma Applied Research…
UPDATE: This study has been completed with the full analysis of all 54 patients. Click here for full results. Earlier this month, during the most…
The Mesothelioma Applied Research Foundation (Meso Foundation) announced this week that Marjorie Zauderer, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center, has been…
On Friday morning, we made our first stop on the 2018 International Symposium on Malignant Mesothelioma tour in Minneapolis, MN! Our executive director Mary Hesdoffer,…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
